Of note, compared to the PAD patients, there was a statistically significant increase in MPO in both AAA groups, while for D-dimer, the cut-off for a statistically significant difference over PAD was only reached in AAA1 but not in the mixed AAA2 cohort. The gene discussed is MPO; the disease is triple-A syndrome.